Hamps Bio Limited (BOM:544312)
25.50
-0.40 (-1.54%)
At close: Sep 7, 2026
Hamps Bio Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 226 | 144 | 186 | - | - | - | |
Market Cap Growth | -10.21% | -22.57% | - | - | - | - |
Enterprise Value | 293 | 171 | 199 | - | - | - |
Last Close Price | 25.90 | 16.55 | 21.38 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | 62.55 | - | - | - |
PS Ratio | 2.66 | 1.70 | 2.79 | - | - | - |
PB Ratio | 2.79 | 1.78 | 2.12 | - | - | - |
P/TBV Ratio | 3.24 | 2.07 | 2.14 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 3.45 | 2.02 | 2.98 | - | - | - |
EV/EBITDA Ratio | 99.79 | 58.32 | 25.22 | - | - | - |
EV/EBIT Ratio | - | - | 48.23 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.85 | 0.85 | 0.34 | 0.31 | 1.27 | 2.03 |
Debt / EBITDA Ratio | 23.46 | 23.46 | 3.76 | 0.88 | 2.01 | 3.32 |
Debt / FCF Ratio | - | - | - | - | 4.34 | 49.00 |
Net Debt / Equity Ratio | 0.83 | 0.83 | 0.33 | 0.30 | 1.24 | 1.98 |
Net Debt / EBITDA Ratio | 22.88 | 22.88 | 3.64 | 0.83 | 1.95 | 3.24 |
Net Debt / FCF Ratio | -1.15 | -1.15 | -0.52 | -1.51 | 4.22 | 47.77 |
Asset Turnover | 0.59 | 0.59 | 0.75 | 1.43 | 1.47 | 1.29 |
Inventory Turnover | 1.34 | 1.34 | 1.18 | 2.27 | 4.07 | 3.86 |
Quick Ratio | 0.72 | 0.72 | 0.95 | 0.75 | 0.39 | 0.41 |
Current Ratio | 1.46 | 1.46 | 2.30 | 1.74 | 0.59 | 0.74 |
Return on Equity (ROE) | -8.74% | -8.74% | 4.90% | 21.27% | 30.31% | 12.63% |
Return on Assets (ROA) | -2.22% | -2.22% | 2.88% | 10.86% | 8.67% | 4.38% |
Return on Invested Capital (ROIC) | -3.45% | -3.86% | 3.80% | 16.45% | 17.44% | 8.85% |
Return on Capital Employed (ROCE) | -4.20% | -4.20% | 3.80% | 21.20% | 28.00% | 15.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -3.27% | -5.12% | 1.60% | - | - | - |
FCF Yield | -25.91% | -40.54% | -29.43% | - | - | - |
Buyback Yield / Dilution | - | - | -122.25% | 26.76% | - | -11.50% |